EventsThe 2nd International Electronic Conference on Foods - "Future Foods and Food Technologies for a Sustainable World"
Published
with-doi10.3390/Foods2021-11084 (registering DOI)
This submission belongs to the session 3. Food Nutrition and Human Health of the event The 2nd International Electronic Conference on Foods - "Future Foods and Food Technologies for a Sustainable World"
Published date
14 Oct, 2021
Academic Editor
author-avatarAntonello Santini
Citation
Gabriele Serreli, Monica Deiana, Maria Paola Melis, Micaela Rita Naitza, Sonia Zodio, Roberto Loi, Giuseppina Sanna, Juan Carlos Morales, Pablo Peñalver, In vivo formed metabolites of polyphenols and their anti-inflammatory efficacy at intestinal level, in Proceedings of The 2nd International Electronic Conference on Foods - "Future Foods and Food Technologies for a Sustainable World", 15 October–30 October 2021, MDPI: Basel, Switzerland, doi: 10.3390/Foods2021-11084
Share
Email
Facebook
Twitter
LinkedIn

In vivo formed metabolites of polyphenols and their anti-inflammatory efficacy at intestinal level

image
Micaela Rita Naitza 2
Sonia Zodio 2
Roberto Loi 2
image
1. Department of Biomedical Sciences, University of Cagliari, Italy
2. Department of Biomedical Sciences, University of Cagliari
3. Department of Biochemistry and Molecular Pharmacology, Institute of Parasitology and Biomedicine López Neyra, CSIC, PTS Granada
Abstract

Introduction: Metabolites of polyphenols recently vested interest because of their actual bioavailability in vivo. In fact, they reach tissue concentrations that are likely responsible for the beneficial effects attributed to ingested polyphenols. The aim of our study was to evaluate the mechanisms of action of different classes of phase I/II metabolites of polyphenols coming from different plant foods against intestinal inflammation and epithelial barrier damage. Metabolites were tested in intestinal cell cultures to assess their efficacy against LPS-induced altered membrane permeability related to disruption and/or relocation of tight junction (TJ) proteins, as well as to the induction of iNOS expression associated to MAPKs and NF-ĸB pathways.

Material and methods: Human colon adenocarcinoma cells (Caco-2), differentiated as normal enterocytes, were treated with LPS (1 µg/mL) following pretreatment with the metabolites at concentration of 1 µM, which can be easily achieved in vivo. Caco-2 monolayers permeability was monitored with time, measuring the transepithelial electrical resistance (TEER). The modulation of MAPKs JNK, p38 and ERK1/2, and TJ zonulin (ZO-1) and occludin modification, were assessed by western blotting and immunofluorescence assays. Moreover, intestinal nitric oxide release consequently to iNOS expression, and modulation of Akt/IĸBα/NF-ĸB pathway were also tested.

Results: Pretreatment with the tested metabolites decreased permeability and preserved TJ integrity. Moreover, LPS-induced MAPKs phosphorylation was significantly reduced. It was also observed that metabolites inhibited iNOS expression and counteracted IĸBα degradation, through a modulatory action involving MAPKs and Akt pathways.

Conclusion: The outcome of this work indicates that metabolites are able to counteract LPS-induced alteration of epithelial permeability mainly through the modulation of MAPKs dependent intracellular signaling, thus they may significantly contribute to preserve the integrity of intestinal mucosa against inflammation related disorders.

Keywords
polyphenols
metabolites
inflammation
MAPK
intestinal permeability
metabolism
Manuscript
Oral Presentation
Total polyphenol content in food samples and nutraceuticals: Antioxidant indexes versus high performance liquid chromatography
The marvellous oregano spices